Skip to content
Home/Companies/MedTech/VIMS

VIMS

MedTech·France·Exited 2024·Held 16yr
Entry
2008
Hold
16yr
Exit
2024

Who owns VIMS?

VIMS is a French MedTech company, now owned by Zimmer Biomet, which acquired it in 2024 from M Capital.

Hand-verified · updated 2026-05-20

Open JSON · CC-BY
M Capital
Investor
M Capital
M Capital Capital Développement · 2010 · Buyout

Key facts

HQFrance
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
Zimmer Biomet
Exit Year
2024

More from M Capital Capital Développement

Other portfolio companies in the same fund.

Asphalte
Asphalte
Active
ConsumerFrance· 2023
The Sanctuary Group
The Sanctuary Group
Active
ConsumerFrance· 2023
Amisco
Active
IndustrialsFrance· 2020
Alsatis
Active
TelecomFrance· 2019
Alsei
Alsei
Active
IndustrialsFrance· 2019
LivinParis
LivinParis
Active
HospitalityFrance· 2019

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns VIMS?

VIMS is now owned by Zimmer Biomet, which acquired it in 2024 from M Capital.

When did Zimmer Biomet acquire VIMS?

Zimmer Biomet acquired VIMS in 2024, buying from M Capital.

Who did VIMS sell to?

M Capital sold VIMS to Zimmer Biomet in 2024 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue